Australian Stocks to Watch: Energy Prices Keep Focus on Growth

Global energy prices continue to be in focus as Middle East risks keep inflation debates alive. For Australian investors, this attention on borrowing costs due to inflation news makes it crucial to look at companies that analysts expect to lift earnings even if interest rates remain sensitive to inflation news.

Elevra Lithium (ASX:ELV) is a Brisbane-based miner focused on lithium, graphite, and gold. The company has its 100% owned North American Lithium project in Quebec as the main engine driving its growth. This project generates about US$201.7 million through production of lithium concentrate for electric vehicle and energy storage supply chains.

Neuren Pharmaceuticals (ASX:NEU) is another biopharma company focused on treatments for rare neurological disorders. Its commercialized drug DAYBUE for Rett syndrome provides the clearest link to the Healthy high growth potential earnings theme. The company has a market value of roughly A$2.58b and recent commercial revenue is almost entirely tied to this therapy.

4DMedical (ASX:4DX) is a medical technology company focused on non-invasive, four-dimensional lung imaging software and scanners that help clinicians track respiratory disease over time. The company currently generates about A$7.1 million in revenue from its lung function analysis activities, largely in the United States.